Owner only: item control page
Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial
Koenigsmann, M, Casper, J, Kahl, C, Basara, N, Sayer, H G, Behre, G, Theurich, S, Christopeit, M
, Mohren, M, Reichle, A, Metzner, B, Ganser, A, Stadler, M, Uharek, L, Balleisen, L, Hinke, A, Hinke, R and Niederwieser, D
(2014)
Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial.
Bone Marrow Transplantation 49 (3), pp. 410-415.
Date of publication of this fulltext: 19 Dec 2024 08:12
Article
Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Bone Marrow Transplantation | ||||
| Publisher: | NATURE PUBLISHING GROUP | ||||
|---|---|---|---|---|---|
| Place of Publication: | LONDON | ||||
| Volume: | 49 | ||||
| Number of Issue or Book Chapter: | 3 | ||||
| Page Range: | pp. 410-415 | ||||
| Date | 2014 | ||||
| Institutions | Medicine > Lehrstuhl für Innere Medizin III (Hämatologie und Internistische Onkologie) | ||||
| Identification Number |
| ||||
| Keywords | STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; NON-HODGKINS-LYMPHOMA; HIGH-DOSE CHEMOTHERAPY; REDUCED-INTENSITY; SALVAGE THERAPY; BLOOD; MALIGNANCIES; FLUDARABINE; RITUXIMAB; relapsed non-Hogkin's lymphoma; treosulfan; autologous transplantation; allogeneic transplantation; risk-adapted; therapy | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 61680 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric